Specific Detection and Enumeration of Burkholderia cepacia Complex by Flow Cytometry Using a Fluorescence-Labeled...

Area of Science:

• Microbiology
• Analytical Chemistry
• Biotechnology

Background:

• Burkholderia cepacia complex (BCC) poses a significant risk, causing recalls of non-sterile pharmaceutical products.
• Rapid, sensitive, and specific detection methods for BCC are crucial for pharmaceutical quality control and patient safety.

Purpose of the Study:

• To develop and validate a rapid flow cytometry-based detection method for Burkholderia cepacia complex (BCC).
• To assess the sensitivity, specificity, and detection limit of the developed assay for pharmaceutical applications.

Main Methods:

• Development of a flow cytometry assay utilizing a fluorescence-labeled oligonucleotide Kef probe.
• Optimization of probe concentration (1 nM), hybridization temperature (60 °C), and time (30 min).
• Validation using BCC and non-BCC species, determination of detection limit, and comparison with culture-based methods.

Main Results:

• The Kef probe flow cytometry assay demonstrated a sensitivity of 90% and specificity of 88.9%.
• The assay achieved a detection limit of 1 CFU/mL for B. cenocepacia AU1054 in water.
• Comparable cell counts were observed between the Kef probe assay and traditional methods in the presence of common pharmaceutical preservatives.

Conclusions:

• The Kef probe flow cytometry method is a rapid, sensitive, and specific tool for detecting BCC contamination.
• This technique presents a viable alternative to culture-based methods for monitoring BCC in non-sterile pharmaceutical raw materials and products.
• The assay's effectiveness in water-based environments supports its application in pharmaceutical quality assurance.